1. Home
  2. SVCO vs VYGR Comparison

SVCO vs VYGR Comparison

Compare SVCO & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVCO
  • VYGR
  • Stock Information
  • Founded
  • SVCO 1984
  • VYGR 2013
  • Country
  • SVCO United States
  • VYGR United States
  • Employees
  • SVCO N/A
  • VYGR N/A
  • Industry
  • SVCO
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVCO
  • VYGR Health Care
  • Exchange
  • SVCO NYSE
  • VYGR Nasdaq
  • Market Cap
  • SVCO 221.9M
  • VYGR 222.9M
  • IPO Year
  • SVCO 2024
  • VYGR 2015
  • Fundamental
  • Price
  • SVCO $4.33
  • VYGR $3.21
  • Analyst Decision
  • SVCO Strong Buy
  • VYGR Strong Buy
  • Analyst Count
  • SVCO 6
  • VYGR 9
  • Target Price
  • SVCO $20.50
  • VYGR $14.86
  • AVG Volume (30 Days)
  • SVCO 113.0K
  • VYGR 393.3K
  • Earning Date
  • SVCO 05-14-2025
  • VYGR 05-12-2025
  • Dividend Yield
  • SVCO N/A
  • VYGR N/A
  • EPS Growth
  • SVCO N/A
  • VYGR N/A
  • EPS
  • SVCO N/A
  • VYGR N/A
  • Revenue
  • SVCO $59,680,000.00
  • VYGR $80,001,000.00
  • Revenue This Year
  • SVCO $18.77
  • VYGR N/A
  • Revenue Next Year
  • SVCO $16.01
  • VYGR $2.04
  • P/E Ratio
  • SVCO N/A
  • VYGR N/A
  • Revenue Growth
  • SVCO 10.02
  • VYGR N/A
  • 52 Week Low
  • SVCO $3.55
  • VYGR $2.75
  • 52 Week High
  • SVCO $21.59
  • VYGR $9.55
  • Technical
  • Relative Strength Index (RSI)
  • SVCO N/A
  • VYGR 40.54
  • Support Level
  • SVCO N/A
  • VYGR $2.75
  • Resistance Level
  • SVCO N/A
  • VYGR $3.34
  • Average True Range (ATR)
  • SVCO 0.00
  • VYGR 0.25
  • MACD
  • SVCO 0.00
  • VYGR 0.04
  • Stochastic Oscillator
  • SVCO 0.00
  • VYGR 59.74

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design ("TCAD") software, electronic data automation ("EDA") software and semiconductor intellectual property ("SIP"). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the "technology behind the chip" and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: